Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19
Open Access
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Foundation for the National Institutes of Health
- Wellcome Trust
This publication has 34 references indexed in Scilit:
- Disease-Regulated Gene Therapy with Anti-Inflammatory Interleukin-10 Under the Control of the CXCL10 Promoter for the Treatment of Rheumatoid ArthritisHuman Gene Therapy, 2016
- The Inflammatory Transcription Factors NFκB, STAT1 and STAT3 Drive Age-Associated Transcriptional Changes in the Human KidneyPLOS Genetics, 2015
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic ArthritisNew England Journal of Medicine, 2012
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic ArthritisNew England Journal of Medicine, 2012
- Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiencyNature Immunology, 2012
- The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR–IL-1R by controlling degradation of regnase-1Nature Immunology, 2011
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman diseaseBlood, 2008
- Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarraysBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008
- The role of cytokine mRNA stability in the pathogenesis of autoimmune diseaseAutoimmunity Reviews, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005